Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 2,022 Cr.
- Current Price ₹ 1,118
- High / Low ₹ 1,316 / 262
- Stock P/E 60.4
- Book Value ₹ 71.5
- Dividend Yield 0.00 %
- ROCE 43.6 %
- ROE 40.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 15.3 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 77 | 137 | |
| 51 | 87 | |
| Operating Profit | 26 | 51 |
| OPM % | 33% | 37% |
| 0 | 1 | |
| Interest | 3 | 4 |
| Depreciation | 1 | 1 |
| Profit before tax | 22 | 47 |
| Tax % | 25% | 27% |
| 16 | 34 | |
| EPS in Rs | 11.88 | 18.49 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 40% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 13 | 18 |
| Reserves | 25 | 111 |
| 27 | 34 | |
| 13 | 22 | |
| Total Liabilities | 78 | 185 |
| 14 | 84 | |
| CWIP | 6 | 0 |
| Investments | 3 | 0 |
| 55 | 101 | |
| Total Assets | 78 | 185 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -10 | 11 | |
| -23 | -63 | |
| 33 | 61 | |
| Net Cash Flow | -0 | 9 |
| Free Cash Flow | -30 | -52 |
| CFO/OP | -38% | 28% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 127 | 138 |
| Inventory Days | 141 | 126 |
| Days Payable | 40 | 49 |
| Cash Conversion Cycle | 228 | 215 |
| Working Capital Days | 129 | 163 |
| ROCE % | 44% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Annual Production Volume lakhs pieces |
|
|||
| Capacity Utilization Rate % |
||||
| Installed Production Capacity lakhs pieces |
||||
| Number of Distributors number |
||||
| Number of Retailers number |
||||
| Number of Super Stockists number |
||||
| Total Manufacturing Lines number |
||||
Extracted by Screener AI
Documents
Announcements
-
Updates
- MD Anupam Ghosh to attend ET Immersions – Japan Edition in Tokyo from 29 Aug to 2 Sep 2026.
-
Outcome of Board Meeting
- Anondita Medicare Limited has informed regarding Outcome of Board Meeting held on August 01, 2026.
-
Giving guarantees/indemnity/ becoming a surety for third party
- Anondita Medicare issued ₹5 crore corporate guarantee to HDFC Bank for subsidiary AHRPIL on July 21, 2026.
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Company held in-person investor meet in Mumbai on July 11, 2026; no UPSI shared.
-
Reply to Clarification- Financial results
- Company clarifies FY26 results query; revised EPS 11.38/20.77 filed May 29, 2026.
Annual reports
No data available.
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT
-
Mar 2026TranscriptAI SummaryPPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.